The biomarker potential of cell‐free microRNA from cerebrospinal fluid in Parkinsonian Syndromes

Abstract

Levels of specific trios of CSF-microRNAs discriminate well between α-synucleinopathies (PD and MSA) and controls. The results need to be validated in larger, independent cohorts. © 2018 International Parkinson and Movement Disorder Society.